MedTrace Logo

Managing Hypertension Among People Living With HIV

NCT05031819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 960

Last updated 2025-11-21

No results posted yet for this study

Summary

The Managing Hypertension Among People Living with HIV: An InTegrated Model (MAP-IT) a stepped wedge, cluster-randomized controlled trial to evaluate the effect of practice facilitation (PF) on the integration of a Task-Shifting Strategy for hypertension (HTN) control (TASSH) into HIV care for management of HTN in people living with HIV (PLWH). The study will recruit 960 PLWH across 30 primary health centers (PHCs) in Akwa Ibom State (32 patients/PHC).

Conditions

  • Blood Pressure
  • Human Immunodeficiency Virus I Infection
  • Acquired Immunodeficiency Syndrome
  • Hypertension

Interventions

OTHER

Nurse-led Task-Shifting Strategy for Hypertension Control (TASSH) plus Practice Facilitation.

* TASSH includes CVD risk assessment; medication initiation and titration; lifestyle counseling and patient referral to physician care for complex cases. * Practice Facilitation includes the training of external experts to support the HIV nurses implementing TASSH

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Dr. Dike Ojji

    lead OTHER

Principal Investigators

  • Dike Ojji, MBBS, Ph.D · University of Abuja

  • Olugbenga Ogedegbe, MD, MPH · NYU Langone Health

  • Juliet Iwelunmor, Ph.D · St. Louis University

  • Angela Attah, MBBS, MPH · FHI 360

  • DANIEL HENRY · Cardiovascular Research Unit, University of Abuja

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-26
Primary Completion
2025-04-30
Completion
2025-10-31

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031819 on ClinicalTrials.gov